Scholar Rock

SRRKNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$5.865 B

$48.16 +3.24%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$378.0M

Loss-making

Shares outstanding

121,785,282

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#19ImmunovantIMVT$7.68B
#20CG OncologyCGON$6.94B
#21Scholar RockSRRK$5.87B
#22CRISPR TherapeuticsCRSP$5.64B
#23Iovance BiotherapeuticsIOVA$4.62B

What if Scholar Rock were worth as much as…

Open the what-if tool →

Gold $30.3T

$248,585.49

Per share 5,162× higher

Bitcoin $1.72T

$14,121.61

Per share 293× higher

Nvidia $5.48T

$44,996.06

Per share 934× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Scholar Rock are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.